Prot #D4190C00010: A Phase 1 Study of MEDI4736 (Anti-PD-L1 Antibody) in Combination with Tremelimumab (Anti-CTLA-4 Antibody) in Subjects with Advanced Solid Tumors

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date9/20/169/20/19

    Funding

    • PRA Health Sciences (Prot #D4190C00010)
    • MedImmune, LLC (Prot #D4190C00010)